Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS (Reuters) – Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year’s annual ‘Choose France’ business summit. Pfizer said it would invest 500 million euros ($538.5 million) in France to build up its research and development work…

Read More